The company's cutting-edge imaging solutions, including their flagship product NeuroQuant®, provide a convenient and cost-effective means for doctors to quantify brain structures and assess neurological conditions such as Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. Their team of scientists, engineers, business professionals, and clinical specialists work towards improving the diagnosis and treatment of patients with neurodegenerative disorders and cancers. NeuroQuant® is the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, bringing sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop or mobile device.